Sign In
Buy CVS
$98.32
-0.84 (-0.85%)
At Close: Jun 18, 2026
Building on 18 months of proven success, the initiative will scale evidence-based solutions to improve pregnancy and postpartum outcomes for New Yorkers NEW YORK, Jan. 14, 2026 /PRNewswire/ -- The CV
CVS Health (CVS) is a Top-Ranked Value Stock: Should You Buy?
10:41am, Tuesday, 13'th Jan 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know
10:01am, Tuesday, 13'th Jan 2026
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
Gilead's new HIV prevention shot added to CVS's drug coverage lists, CEO says
03:58pm, Monday, 12'th Jan 2026
Gilead Sciences' new HIV prevention drug has been added to CVS Health's commercial insurance plans, the drugmaker's CEO Daniel O'Day said at a major industry conference that kicked off on Monday in Sa
Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?
01:10pm, Monday, 12'th Jan 2026
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why CVS Health (CVS) is a Top Momentum Stock for the Long-Term
10:50am, Monday, 12'th Jan 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Hennion & Walsh Asset Management Inc. Makes New $564,000 Investment in CVS Health Corporation $CVS
05:02am, Sunday, 11'th Jan 2026
Hennion and Walsh Asset Management Inc. purchased a new position in shares of CVS Health Corporation (NYSE: CVS) in the undefined quarter, according to its most recent filing with the Securities and E
CVS Health to hold fourth quarter and full year 2025 earnings conference call
09:00am, Friday, 09'th Jan 2026
WOONSOCKET, R.I., Jan. 9, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, February 11th, 2026, at 8:00 a.m.
Can These Dividend Stocks Beat the Market Again in 2026?
08:37am, Thursday, 08'th Jan 2026
Building on a strong 2025, CVS Health's outlook for 2026 and beyond looks promising. Amgen is developing newer drug products that will address a recent patent cliff.
First Look: Apple-JPM card deal, Ford L3, defense clampdown
07:38am, Thursday, 08'th Jan 2026
Stock News Trump targets Wall Street homebuying: President Trump proposed banning large institutional investors from purchasing single-family homes, sending sha
CVS Health (CVS) Suffers a Larger Drop Than the General Market: Key Insights
06:46pm, Wednesday, 07'th Jan 2026
CVS Health (CVS) closed at $79.79 in the latest trading session, marking a -1.13% move from the prior day.
Are CVS, UnitedHealth, Cigna Hiding Billions In PBM Rebates? New Report Claims They Are
06:35pm, Tuesday, 06'th Jan 2026
A new report from Hunterbrook Media investigates how the three biggest health care giants in the U.S.— CVS Health Corp. (NASDAQ:CVS), UnitedHealth Group, Inc. (NYSE:UNH) and Cigna Group (NYSE:CI) �
CVS Health declares quarterly dividend
08:59am, Tuesday, 06'th Jan 2026
WOONSOCKET, R.I., Jan. 6, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per s
Community Trust & Investment Co. Trims Stock Position in CVS Health Corporation $CVS
04:48am, Tuesday, 06'th Jan 2026
Community Trust and Investment Co. decreased its position in CVS Health Corporation (NYSE: CVS) by 3.1% in the undefined quarter, according to the company in its most recent 13F filing with the Securi
CapWealth Advisors LLC Sells 7,924 Shares of CVS Health Corporation $CVS
04:34am, Friday, 02'nd Jan 2026
CapWealth Advisors LLC cut its stake in shares of CVS Health Corporation (NYSE: CVS) by 2.4% in the third quarter, according to the company in its most recent filing with the Securities and Exchange C
